ECM
AVNS

ExodusPoint Capital Management’s Avanos Medical AVNS Stock Holding History

ExodusPoint Capital Management’s Portfolio AVNS Stock Details AVNS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$5.91M Sell
421,504
-164,981
-28% -$2.22M 0.05% 387
2025
Q4 		$6.59M Buy
586,485
+222,292
+61% +$2.54M 0.05% 381
2025
Q3 		$4.21M Sell
364,193
-883,744
-71% -$10.3M 0.04% 473
2025
Q2 		$15.3M Buy
1,247,937
+1,217,519
+4,003% +$15.3M 0.13% 147
2025
Q1 		$436K Buy
+30,418
New +$475K ﹤0.01% 1140
2024
Q3 		– Sell
-59,642
Closed -$1.19M – 1614
2024
Q2 		$1.19M Buy
59,642
+22,428
+60% +$437K 0.01% 963
2024
Q1 		$741K Buy
+37,214
New +$719K 0.01% 1038
2023
Q4 		– Sell
-93,976
Closed -$1.9M – 1468
2023
Q3 		$1.9M Buy
93,976
+42,000
+81% +$952K 0.02% 687
2023
Q2 		$1.33M Buy
51,976
+44,499
+595% +$1.17M 0.01% 988
2023
Q1 		$222K Buy
+7,477
New +$217K ﹤0.01% 1553
2022
Q2 		– Sell
-21,428
Closed -$718K – 1924
2022
Q1 		$718K Buy
21,428
+12,212
+133% +$393K 0.01% 1339
2021
Q4 		$320K Sell
9,216
-19,418
-68% -$628K ﹤0.01% 1636
2021
Q3 		$893K Sell
28,634
-48,526
-63% -$1.65M 0.01% 1076
2021
Q2 		$2.81M Buy
77,160
+55,276
+253% +$2.29M 0.03% 541
2021
Q1 		$957K Sell
21,884
-44,596
-67% -$2.09M 0.01% 942
2020
Q4 		$3.05M Sell
66,480
-51,657
-44% -$2.15M 0.03% 395
2020
Q3 		$3.92M Buy
118,137
+22,559
+24% +$721K 0.08% 220
2020
Q2 		$2.81M Buy
95,578
+75,879
+385% +$2.2M 0.07% 309
2020
Q1 		$530K Buy
+19,699
New +$588K 0.03% 466

Other funds holding AVNS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Thrivent Financial for Lutherans
Thrivent Financial for Lutherans Minneapolis, Minnesota $52.5B AUM 27.12% 1-Year Est. Return

ExodusPoint Capital Management's AVNS Position: Q1 2026 in Review

ExodusPoint Capital Management reduced its Avanos Medical (AVNS) stake by 28% in Q1 2026, selling an estimated $2.22M and leaving 421,504 shares worth $5.91M. The position accounts for 0.05% of the portfolio, ranked #387.

ExodusPoint Capital Management first reported a position in AVNS in Q1 2020 and has held it in 19 quarters since. The position peaked at $15.3M in Q2 2025. 257 funds tracked by Wall St. Rank hold AVNS as of Q1 2026.

  • ExodusPoint Capital Management held 421,504 shares of Avanos Medical worth $5.91M as of Q1 2026.
  • ExodusPoint Capital Management sold 164,981 Avanos Medical shares in Q1 2026, an estimated $2.22M.
  • Avanos Medical made up 0.05% of ExodusPoint Capital Management's portfolio in Q1 2026, its #387 holding.
  • ExodusPoint Capital Management first reported a position in Avanos Medical in Q1 2020 and has held it in 19 quarters since.
  • ExodusPoint Capital Management's Avanos Medical position peaked at $15.3M in Q2 2025.
  • 257 funds tracked by Wall St. Rank held Avanos Medical as of Q1 2026.

Based on ExodusPoint Capital Management's 13F filing for Q1 2026, filed 14 May 2026.